The neurobiology of suicide - A Review of post-mortem studies

Conwell Y, Duberstein PR, Cox C, Herrmann JH, Forbes NT, Caine ED: Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry 1996, 153: 1001–1008. Harris EC, Barraclough B: Suicide as an outcome for mental disorders. A meta- analysis. Br J Psychiatry 1997, 170: 205–228. 10.1192/bjp.170.3.205 Henriksson MM, Aro HM, Marttunen MJ, Heikkinen ME, Isometsa ET, Kuoppasalmi KI, Lonnqvist JK: Mental disorders and comorbidity in suicide. Am J Psychiatry 1993, 150: 935–940. Westrin A: Stress system alterations and mood disorders in suicidal patients. A review. Biomed Pharmacother 2000, 54: 142–145. 10.1016/S0753-3322(00)89047-2 McGirr A, Turecki G: The relationship of impulsive aggressiveness to suicidality and other depression-linked behaviors. Curr Psychiatry Rep 2007, 9: 460–466. 10.1007/s11920-007-0062-2 Scott KM, Hwang I, Chiu WT, Kessler RC, Sampson NA, Angermeyer M, Beautrais A, Borges G, Bruffaerts R, de Graaf R, Florescu S, Fukao A, Haro JM, Hu C, Kovess V, Levinson D, Posada-Villa J, Scocco P, Nock MK: Chronic physical conditions and their association with first onset of suicidal behavior in the world mental health surveys. Psychosom Med 2010, 72: 712–719. 10.1097/PSY.0b013e3181e3333d Beck AT, Steer RA, Beck JS, Newman CF: Hopelessness, depression, suicidal ideation, and clinical diagnosis of depression. Suicide Life Threat Behav 1993, 23: 139–145. Au AC, Lau S, Lee MT: Suicide ideation and depression: the moderation effects of family cohesion and social self-concept. Adolescence 2009, 44: 851–868. Hafner H: [The epidemiology of suicide and attempted suicide]. Psychiatr Neurol Med Psychol (Leipz) 1989, 41: 449–475. Asberg M, Traskman L, Thoren P: 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976, 33: 1193–1197. 10.1001/archpsyc.1976.01770100055005 Nordstrom P, Samuelsson M, Asberg M, Traskman-Bendz L, Aberg-Wistedt A, Nordin C, Bertilsson L: CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994, 24: 1–9. Pandey GN, Pandey SC, Dwivedi Y, Sharma RP, Janicak PG, Davis JM: Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. Am J Psychiatry 1995, 152: 850–855. van Praag HM: CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet 1983, 2: 977–978. McGirr A, Diaconu G, Berlim MT, Pruessner JC, Sable R, Cabot S, Turecki G: Dysregulation of the sympathetic nervous system, hypothalamic-pituitary-adrenal axis and executive function in individuals at risk for suicide. J Psychiatry Neurosci 2010, 35: 399–408. 10.1503/jpn.090121 Sunnqvist C, Westrin A, Traskman-Bendz L: Suicide attempters: biological stressmarkers and adverse life events. Eur Arch Psychiatry Clin Neurosci 2008, 258: 456–462. 10.1007/s00406-008-0819-6 Kamali M, Saunders EF, Prossin AR, Brucksch CB, Harrington GJ, Langenecker SA, McInnis MG: Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar disorder. J Affect Disord 2012, 136: 350–358. 10.1016/j.jad.2011.11.027 Greenhalgh T: How to read a paper: Papers that summarise other papers systematic reviews and meta-analyses). BMJ 1997, 315: 672–675. 10.1136/bmj.315.7109.672 Schmitt A, Parlapani E, Bauer M, Heinsen H, Falkai P: Is brain banking of psychiatric cases valuable for neurobiological research? Clinics (Sao Paulo) 2008, 63: 255–266. Monoranu CM, Grunblatt E, Bartl J, Meyer A, Apfelbacher M, Keller D, Michel TM, Al- Saraj S, Schmitt A, Falkai P, Roggendorf W, Deckert J, Ferrer I, Riederer P: Methyl- and acetyltransferases are stable epigenetic markers postmortem. Cell Tissue Bank 2011, 12: 289–297. 10.1007/s10561-010-9199-z Grunblatt E, Proft F, Apfelbacher M, Deckert J, Roggendorf W, Riederer P, Monoranu CM: Brain tryptophan rather than pH-value is altered as consequence of artificial postmortem interval and storage conditions. Neurochem Int 2010, 57: 819–822. 10.1016/j.neuint.2010.08.020 Bell JE, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Budka H, Dexter DT, Falkai P, Ferrer I, Gelpi E, Gentleman SM, Giaccone G, Huitinga I, Ironside JW, Klioueva N, Kovacs GG, Meyronet D, Palkovits M, Parchi P, Patsouris E, Reynolds R, Riederer P, Roggendorf W, Seilhean D, Schmitt A, Schmitz P, Streichenberger N, Schwalber A, Kretzschmar H: Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. Acta Neuropathol 2008, 115: 497–507. 10.1007/s00401-008-0360-8 Sequeira A, Kim C, Seguin M, Lesage A, Chawky N, Desautels A, Tousignant M, Vanier C, Lipp O, Benkelfat C, Rouleau G, Turecki G: Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior. Am J Med Genet B Neuropsychiatr Genet 2003, 119B: 108–113. 10.1002/ajmg.b.20011 Swift RG, Sadler DB, Swift M: Psychiatric findings in Wolfram syndrome homozygotes. Lancet 1990, 336: 667–669. 10.1016/0140-6736(90)92157-D Kunugi H, Hashimoto R, Yoshida M, Tatsumi M, Kamijima K: A missense polymorphism (S205L) of the low-affinity neurotrophin receptor p75NTR gene is associated with depressive disorder and attempted suicide. Am J Med Genet B Neuropsychiatr Genet 2004, 129B: 44–46. 10.1002/ajmg.b.30062 Iwamoto K, Bundo M, Kato T: Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 2005, 14: 241–253. Konradi C: Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Brain Res Brain Res Rev 2005, 50: 142–155. 10.1016/j.brainresrev.2005.05.004 Must A, Koks S, Vasar E, Tasa G, Lang A, Maron E, Vali M: Common variations in 4p locus are related to male completed suicide. Neuromolecular Med 2009, 11: 13–19. 10.1007/s12017-008-8056-8 Sequeira A, Klempan T, Canetti L, Ffrench-Mullen J, Benkelfat C, Rouleau GA, Turecki G: Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry 2007, 12: 640–655. 10.1038/sj.mp.4001969 Glare EM, Divjak M, Bailey MJ, Walters EH: beta-Actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mRNA levels. Thorax 2002, 57: 765–770. 10.1136/thorax.57.9.765 Shi Q, Pavey ES, Carter RE: Bonferroni-based correction factor for multiple, correlated endpoints. Pharm Stat 2012, 11: 300–309. 10.1002/pst.1514 Yang G, Gong YD, Gong K, Jiang WL, Kwon E, Wang P, Zheng H, Zhang XF, Gan WB, Zhao NM: Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2. Neurosci Lett 2005, 384: 66–71. 10.1016/j.neulet.2005.04.040 Ferguson GD, Herschman HR, Storm DR: Reduced anxiety and depression-like behavior in synaptotagmin IV (−/−) mice. Neuropharmacology 2004, 47: 604–611. 10.1016/j.neuropharm.2004.05.008 Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V, Rehal S, Klempan T, Gratton A, Benkelfat C, Rouleau GA, Mechawar N, Turecki G: Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009, 4: e6585. 10.1371/journal.pone.0006585 Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N: Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 2002, 20: 171–175. 10.1002/cbf.940 Thalmeier A, Dickmann M, Giegling I, Schneider B, MH A, Maurer K, Schnabel A, Kauert G, Moller HJ, Rujescu D: Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims. Int J Neuropsychopharmacol 2008, 11: 217–228. Kim S, Choi KH, Baykiz AF, Gershenfeld HK: Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 2007, 8: 413. 10.1186/1471-2164-8-413 Sibille E, Arango V, Galfalvy HC, Pavlidis P, Erraji-Benchekroun L, Ellis SP, John Mann J: Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology 2004, 29: 351–361. 10.1038/sj.npp.1300335 Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith I, Hochstrasser DF, Williams KL: Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev 1996, 13: 19–50. 10.1080/02648725.1996.10647923 Hunnerkopf R, Grassl J, Thome J: [Proteomics: biomarker research in psychiatry]. Fortschr Neurol Psychiatr 2007, 75: 579–586. 10.1055/s-2007-959249 Schlicht K, Büttner A, Siedler F, Scheffer B, Zill P, Eisenmenger W, Ackenheil M, Bondy B: Comparative proteomic analysis with postmortem prefrontal cortex tissues of suicide victims versus controls. J Psychiatr Res 2007, 41: 493–501. 10.1016/j.jpsychires.2006.04.006 Eng LF, Ghirnikar RS, Lee YL: Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochem Res 2000, 25: 1439–1451. 10.1023/A:1007677003387 Webster MJ, Knable MB, Johnston-Wilson N, Nagata K, Inagaki M, Yolken RH: Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immun 2001, 15: 388–400. 10.1006/brbi.2001.0646 De Leo ME, Borrello S, Passantino M, Palazzotti B, Mordente A, Daniele A, Filippini V, Galeotti T, Masullo C: Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease. Neurosci Lett 1998, 250: 173–176. 10.1016/S0304-3940(98)00469-8 Michel TM, Frangou S, Camara S, Thiemeyer D, Jecel J, Tatschner T, Zoechling R, Grunblatt E: Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur Psychiatry 2008, 23: 413–420. 10.1016/j.eurpsy.2008.06.001 Michel TM, Thome J, Martin D, Nara K, Zwerina S, Tatschner T, Weijers HG, Koutsilieri E: Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis. J Neural Transm 2004, 111: 1191–1201. Pae CU, Yoon SJ, Patkar A, Kim JJ, Jun TY, Lee C, Paik IH: Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism and mood disorders: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30: 1326–1329. 10.1016/j.pnpbp.2006.03.009 Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP: Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 2003, 121: 109–122. 10.1016/S0165-1781(03)00220-8 Brunner J, Bronisch T, Uhr M, Ising M, Binder E, Holsboer F, Turck CW: Proteomic analysis of the CSF in unmedicated patients with major depressive disorder reveals alterations in suicide attempters. Eur Arch Psychiatry Clin Neurosci 2005, 255: 438–440. 10.1007/s00406-005-0575-9 Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G: Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 1998, 18: 7394–7401. Matsubara S, Arora RC, Meltzer HY: Serotonergic measures in suicide brain: 5- HT1A binding sites in frontal cortex of suicide victims. J Neural Transm Gen Sect 1991, 85: 181–194. 10.1007/BF01244944 Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J: Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol Psychiatry 1994, 35: 457–463. 10.1016/0006-3223(94)90044-2 Lowther S, De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW: 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J Affect Disord 1997, 42: 199–207. 10.1016/S0165-0327(96)01413-9 Stockmeier CA, Dilley GE, Shapiro LA, Overholser JC, Thompson PA, Meltzer HY: Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 1997, 16: 162–173. 10.1016/S0893-133X(96)00170-4 Stockmeier CA, Howley E, Shi X, Sobanska A, Clarke G, Friedman L, Rajkowska G: Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder. J Psychiatr Res 2009, 43: 887–894. 10.1016/j.jpsychires.2009.01.001 Arango V, Underwood MD, Gubbi AV, Mann JJ: Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 1995, 688: 121–133. 10.1016/0006-8993(95)00523-S Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE: Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 1993, 8: 315–336. 10.1038/npp.1993.32 Gingrich JA, Hen R: Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 2001, 155: 1–10. 10.1007/s002130000573 New AS, Gelernter J, Goodman M, Mitropoulou V, Koenigsberg H, Silverman J, Siever LJ: Suicide, impulsive aggression, and HTR1B genotype. Biol Psychiatry 2001, 50: 62–65. 10.1016/S0006-3223(01)01108-8 Huang YY, Grailhe R, Arango V, Hen R, Mann JJ: Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology 1999, 21: 238–246. 10.1016/S0893-133X(99)00030-5 Huang YY, Oquendo MA, Friedman JM, Greenhill LL, Brodsky B, Malone KM, Khait V, Mann JJ: Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism. Neuropsychopharmacology 2003, 28: 163–169. 10.1038/sj.npp.1300000 Stefulj J, Büttner A, Kubat M, Zill P, Balija M, Eisenmenger W, Bondy B, Jernej B: 5HT-2C receptor polymorphism in suicide victims. Association studies in German and Slavic populations. Eur Arch Psychiatry Clin Neurosci 2004, 254: 224–227. Stanley M, Mann JJ: Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983, 1: 214–216. Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, Reis DJ, Mann JJ: Autoradiographic demonstration of increased serotonin 5-HT2 and beta- adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990, 47: 1038–1047. 10.1001/archpsyc.1990.01810230054009 Arora RC, Meltzer HY: 3H-imipramine binding in the frontal cortex of suicides. Psychiatry Res 1989, 30: 125–135. 10.1016/0165-1781(89)90154-6 Mann JJ, Stanley M, McBride PA, McEwen BS: Increased serotonin2 and beta- adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 1986, 43: 954–959. 10.1001/archpsyc.1986.01800100048007 Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Pandey SC, Pesold C, Roberts RC, Conley RR, Tamminga CA: Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 2002, 159: 419–429. 10.1176/appi.ajp.159.3.419 Turecki G, Briere R, Dewar K, Antonetti T, Lesage AD, Seguin M, Chawky N, Vanier C, Alda M, Joober R, Benkelfat C, Rouleau GA: Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999, 156: 1456–1458. Yates M, Leake A, Candy JM, Fairbairn AF, McKeith IG, Ferrier IN: 5HT2 receptor changes in major depression. Biol Psychiatry 1990, 27: 489–496. 10.1016/0006-3223(90)90440-D Crow TJ, Cross AJ, Cooper SJ, Deakin JF, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R: Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 1984, 23: 1561–1569. 10.1016/0028-3908(84)90100-X Lowther S, De Paermentier F, Crompton MR, Katona CL, Horton RW: Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res 1994, 642: 281–289. 10.1016/0006-8993(94)90932-6 Owen F, Cross AJ, Crow TJ, Deakin JF, Ferrier IN, Lofthouse R, Poulter M: Brain 5- HT-2 receptors and suicide. Lancet 1983, 2: 1256. Rosel P, Arranz B, San L, Vallejo J, Crespo JM, Urretavizcaya M, Navarro MA: Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims. Psychiatry Res 2000, 99: 173–181. 10.1016/S0925-4927(00)00076-7 Gross-Isseroff R, Dillon KA, Fieldust SJ, Biegon A: Autoradiographic analysis of alpha 1-noradrenergic receptors in the human brain postmortem. Effect of suicide. Arch Gen Psychiatry 1990, 47: 1049–1053. 10.1001/archpsyc.1990.01810230065010 Escriba PV, Ozaita A, Garcia-Sevilla JA: Increased mRNA expression of alpha2A- adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology 2004, 29: 1512–1521. 10.1038/sj.npp.1300459 Shelton RC, Sanders-Bush E, Manier DH, Lewis DA: Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 2009, 158: 1406–1415. 10.1016/j.neuroscience.2008.11.036 Barnes NM, Sharp T: A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38: 1083–1152. 10.1016/S0028-3908(99)00010-6 Giorgetti M, Tecott LH: Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems. Eur J Pharmacol 2004, 488: 1–9. Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Faludi G, Sarosi A, Palkovits M: Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide. Neurochem Res 2006, 31: 167–176. 10.1007/s11064-005-9006-6 Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB: Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997, 387: 303–308. 10.1038/387303a0 Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C: Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002, 34: 349–356. 10.1016/S0896-6273(02)00660-8 Dracheva S, Chin B, Haroutunian V: Altered serotonin 2C receptor RNA splicing in suicide: association with editing. Neuroreport 2008, 19: 379–382. 10.1097/WNR.0b013e3282f556d2 Wang Q, O'Brien PJ, Chen CX, Cho DS, Murray JM, Nishikura K: Altered G protein- coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J Neurochem 2000, 74: 1290–1300. 10.1046/j.1471-4159.2000.741290.x Lappalainen J, Long JC, Virkkunen M, Ozaki N, Goldman D, Linnoila M: HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses. Biol Psychiatry 1999, 46: 821–826. 10.1016/S0006-3223(98)00361-8 Stefulj J, Büttner A, Skavic J, Zill P, Balija M, Eisenmenger W, Bondy B, Jernej B: Serotonin 1B (5HT-1B) receptor polymorphism (G861C) in suicide victims: association studies in German and Slavic population. Am J Med Genet B Neuropsychiatr Genet 2004, 127B: 48–50. 10.1002/ajmg.b.20174 Videtic A, Peternelj TT, Zupanc T, Balazic J, Komel R: Promoter and functional polymorphisms of HTR2C and suicide victims. Genes Brain Behav 2009, 8: 541–545. 10.1111/j.1601-183X.2009.00505.x Underwood MD, Khaibulina AA, Ellis SP, Moran A, Rice PM, Mann JJ, Arango V: Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol Psychiatry 1999, 46: 473–483. 10.1016/S0006-3223(99)00043-8 Boldrini M, Underwood MD, Mann JJ, Arango V: More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res 2005, 1041: 19–28. 10.1016/j.brainres.2005.01.083 Zill P, Büttner A, Eisenmenger W, Bondy B, Ackenheil M: Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. Eur Neuropsychopharmacol 2004, 14: 282–284. 10.1016/j.euroneuro.2003.10.002 Zill P, Büttner A, Eisenmenger W, Moller HJ, Bondy B, Ackenheil M: Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry 2004, 56: 581–586. 10.1016/j.biopsych.2004.07.015 Ono H, Shirakawa O, Kitamura N, Hashimoto T, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, Maeda K: Tryptophan hydroxylase immunoreactivity is altered by the genetic variation in postmortem brain samples of both suicide victims and controls. Mol Psychiatry 2002, 7: 1127–1132. 10.1038/sj.mp.4001150 Purselle DC, Nemeroff CB: Serotonin transporter: a potential substrate in the biology of suicide. Neuropsychopharmacology 2003, 28: 613–619. 10.1038/sj.npp.1300092 Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V: A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 2000, 57: 729–738. 10.1001/archpsyc.57.8.729 Bligh-Glover W, Kolli TN, Shapiro-Kulnane L, Dilley GE, Friedman L, Balraj E, Rajkowska G, Stockmeier CA: The serotonin transporter in the midbrain of suicide victims with major depression. Biol Psychiatry 2000, 47: 1015–1024. 10.1016/S0006-3223(99)00313-3 Parsey RV, Hastings RS, Oquendo MA, Hu X, Goldman D, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ: Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry 2006, 163: 48–51. 10.1176/appi.ajp.163.1.48 Shioe K, Ichimiya T, Suhara T, Takano A, Sudo Y, Yasuno F, Hirano M, Shinohara M, Kagami M, Okubo Y, Nankai M, Kanba S: No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 2003, 48: 184–188. 10.1002/syn.10204 Zupanc T, Pregelj P, Tomori M, Komel R, Paska AV: No association between polymorphisms in four serotonin receptor genes, serotonin transporter gene and alcohol-related suicide. Psychiatr Danub 2010, 22: 522–527. Arango V, Ernsberger P, Sved AF, Mann JJ: Quantitative autoradiography of alpha 1- and alpha 2-adrenergic receptors in the cerebral cortex of controls and suicide victims. Brain Res 1993, 630: 271–282. 10.1016/0006-8993(93)90666-B Meana JJ, Garcia-Sevilla JA: Increased alpha 2-adrenoceptor density in the frontal cortex of depressed suicide victims. J Neural Transm 1987, 70: 377–381. 10.1007/BF01253612 Gonzalez AM, Pascual J, Meana JJ, Barturen F, del Arco C, Pazos A, Garcia-Sevilla JA: Autoradiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims. J Neurochem 1994, 63: 256–265. Ordway GA, Widdowson PS, Smith KS, Halaris A: Agonist binding to alpha 2- adrenoceptors is elevated in the locus coeruleus from victims of suicide. J Neurochem 1994, 63: 617–624. Ordway GA: Pathophysiology of the locus coeruleus in suicide. Ann N Y Acad Sci 1997, 836: 233–252. 10.1111/j.1749-6632.1997.tb52363.x Gross-Isseroff R, Weizman A, Fieldust SJ, Israeli M, Biegon A: Unaltered alpha(2)- noradrenergic/imidazoline receptors in suicide victims: a postmortem brain autoradiographic analysis. Eur Neuropsychopharmacol 2000, 10: 265–271. Schambra UB, Mackensen GB, Stafford-Smith M, Haines DE, Schwinn DA: Neuron specific alpha-adrenergic receptor expression in human cerebellum: implications for emerging cerebellar roles in neurologic disease. Neuroscience 2005, 135: 507–523. 10.1016/j.neuroscience.2005.06.021 Szot P, White SS, Greenup JL, Leverenz JB, Peskind ER, Raskind MA: Alpha1- adrenoreceptor in human hippocampus: binding and receptor subtype mRNA expression. Brain Res Mol Brain Res 2005, 139: 367–371. 10.1016/j.molbrainres.2005.06.013 De Paermentier F, Mauger JM, Lowther S, Crompton MR, Katona CL, Horton RW: Brain alpha-adrenoceptors in depressed suicides. Brain Res 1997, 757: 60–68. 10.1016/S0006-8993(97)00138-8 Meana JJ, Barturen F, Garcia-Sevilla JA: Alpha 2-adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol Psychiatry 1992, 31: 471–490. 10.1016/0006-3223(92)90259-3 Callado LF, Meana JJ, Grijalba B, Pazos A, Sastre M, Garcia-Sevilla JA: Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims. J Neurochem 1998, 70: 1114–1123. Gonzalez-Maeso J, Rodriguez-Puertas R, Meana JJ, Garcia-Sevilla JA, Guimon J: Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)- adrenoceptors. Mol Psychiatry 2002, 7: 755–767. 10.1038/sj.mp.4001067 Garcia-Sevilla JA, Escriba PV, Ozaita A, La Harpe R, Walzer C, Eytan A, Guimon J: Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J Neurochem 1999, 72: 282–291. Arango V, Underwood MD, Mann JJ: Alterations in monoamine receptors in the brain of suicide victims. J Clin Psychopharmacol 1992, 12: 8S-12S. 10.1097/00004714-199204001-00001 Gurguis GN, Turkka J, Laruelle M, Kleinman J, Linnoila M: Coupling efficiency of brain beta-adrenergic receptors to Gs protein in suicide, alcoholism and control subjects. Psychopharmacology (Berl) 1999, 145: 31–38. 10.1007/s002130051029 Little KY, Ranc J, Gilmore J, Patel A, Clark TB: Lack of pineal beta-adrenergic receptor alterations in suicide victims with major depression. Psychoneuroendocrinology 1997, 22: 53–62. 10.1016/S0306-4530(96)00031-5 Sastre M, Guimon J, Garcia-Sevilla JA: Relationships between beta- and alpha2- adrenoceptors and G coupling proteins in the human brain: effects of age and suicide. Brain Res 2001, 898: 242–255. 10.1016/S0006-8993(01)02190-4 Sequeira A, Mamdani F, Lalovic A, Anguelova M, Lesage A, Seguin M, Chawky N, Desautels A, Turecki G: Alpha 2A adrenergic receptor gene and suicide. Psychiatry Res 2004, 125: 87–93. 10.1016/j.psychres.2003.12.002 Martin-Guerrero I, Callado LF, Saitua K, Rivero G, Garcia-Orad A, Meana JJ: The N251K functional polymorphism in the alpha(2A)-adrenoceptor gene is not associated with depression: a study in suicide completers. Psychopharmacology (Berl) 2006, 184: 82–86. 10.1007/s00213-005-0266-2 Fukutake M, Hishimoto A, Nishiguchi N, Nushida H, Ueno Y, Shirakawa O, Maeda K: Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32: 1428–1433. 10.1016/j.pnpbp.2008.02.003 Molnar S, Mihanovic M, Grah M, Kezic S, Filakovic P, Degmecic D: Comparative study on gene tags of the neurotransmission system in schizophrenic and suicidal subjects. Coll Antropol 2010, 34: 1427–1432. Arango V, Underwood MD, Mann JJ: Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol Psychiatry 1996, 39: 112–120. 10.1016/0006-3223(95)00107-7 Nowak G, Szewczyk B, Sadlik K, Piekoszewski W, Trela F, Florek E, Pilc A: Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims. Pol J Pharmacol 2003, 55: 455–459. Persson ML, Wasserman D, Geijer T, Jonsson EG, Terenius L: Tyrosine hydroxylase allelic distribution in suicide attempters. Psychiatry Res 1997, 72: 73–80. 10.1016/S0165-1781(97)00068-1 De Luca V, Strauss J, Kennedy JL: Power based association analysis (PBAT) of serotonergic and noradrenergic polymorphisms in bipolar patients with suicidal behaviour. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32: 197–203. 10.1016/j.pnpbp.2007.08.008 Hattori H, Shirakawa O, Nishiguchi N, Nushida H, Ueno Y, Maeda K: No evidence of an association between tyrosine hydroxylase gene polymorphisms and suicide victims. Kobe J Med Sci 2006, 52: 195–200. Biegon A, Fieldust S: Reduced tyrosine hydroxylase immunoreactivity in locus coeruleus of suicide victims. Synapse 1992, 10: 79–82. 10.1002/syn.890100111 Ettinger U, Kumari V, Collier DA, Powell J, Luzi S, Michel TM, Zedomi O, Williams SC: Catechol-O-methyltransferase (COMT) val158met genotype is associated with BOLD response as a function of task characteristic. Neuropsychopharmacology 2008, 33: 3046–3057. 10.1038/sj.npp.1301658 Sheldrick AJ, Krug A, Markov V, Leube D, Michel TM, Zerres K, Eggermann T, Kircher T: Effect of COMT val158met genotype on cognition and personality. Eur Psychiatry 2008, 23: 385–389. 10.1016/j.eurpsy.2008.05.002 Ono H, Shirakawa O, Nushida H, Ueno Y, Maeda K: Association between catechol- O-methyltransferase functional polymorphism and male suicide completers. Neuropsychopharmacology 2004, 29: 1374–1377. 10.1038/sj.npp.1300470 Bowden C, Cheetham SC, Lowther S, Katona CL, Crompton MR, Horton RW: Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res 1997, 769: 135–140. 10.1016/S0006-8993(97)00692-6 Allard P, Norlen M: Unchanged density of caudate nucleus dopamine uptake sites in depressed suicide victims. J Neural Transm 1997, 104: 1353–1360. 10.1007/BF01294736 Feldcamp LA, Souza RP, Romano-Silva M, Kennedy JL, Wong AH: Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia. Schizophr Res 2008, 103: 192–200. 10.1016/j.schres.2008.05.014 Nowak G, Ordway GA, Paul IA: Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 1995, 675: 157–164. 10.1016/0006-8993(95)00057-W Palmer AM, Burns MA, Arango V, Mann JJ: Similar effects of glycine, zinc and an oxidizing agent on [3H]dizocilpine binding to the N-methyl-D-aspartate receptor in neocortical tissue from suicide victims and controls. J Neural Transm Gen Sect 1994, 96: 1–8. 10.1007/BF01277923 Holemans S, De Paermentier F, Horton RW, Crompton MR, Katona CL, Maloteaux JM: NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides. Brain Res 1993, 616: 138–143. 10.1016/0006-8993(93)90202-X Freed WJ, Dillon-Carter O, Kleinman JE: Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide. Exp Neurol 1993, 121: 48–56. 10.1006/exnr.1993.1070 Noga JT, Hyde TM, Herman MM, Spurney CF, Bigelow LB, Weinberger DR, Kleinman JE: Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains. Synapse 1997, 27: 168–176. 10.1002/(SICI)1098-2396(199711)27:3<168::AID-SYN2>3.0.CO;2-B Kalkman HO: Circumstantial evidence for a role of glutamine-synthetase in suicide. Med Hypotheses 2011, 76: 905–907. 10.1016/j.mehy.2011.03.005 Marcus SR, Nadiger HA, Chandrakala MV, Rao TI, Sadasivudu B: Acute and short- term effects of lithium on glutamate metabolism in rat brain. Biochem Pharmacol 1986, 35: 365–369. 10.1016/0006-2952(86)90206-6 Cheetham SC, Crompton MR, Katona CL, Parker SJ, Horton RW: Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims. Brain Res 1988, 460: 114–123. 10.1016/0006-8993(88)91211-5 Vinod KY, Arango V, Xie S, Kassir SA, Mann JJ, Cooper TB, Hungund BL: Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims. Biol Psychiatry 2005, 57: 480–486. 10.1016/j.biopsych.2004.11.033 Hungund BL, Vinod KY, Kassir SA, Basavarajappa BS, Yalamanchili R, Cooper TB, Mann JJ, Arango V: Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 2004, 9: 184–190. 10.1038/sj.mp.4001376 Dwivedi Y, Conley RR, Roberts RC, Tamminga CA, Pandey GN: [(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims. Am J Psychiatry 2002, 159: 66–73. 10.1176/appi.ajp.159.1.66 Dwivedi Y, Rizavi HS, Shukla PK, Lyons J, Faludi G, Palkovits M, Sarosi A, Conley RR, Roberts RC, Tamminga CA, Pandey GN: Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatry 2004, 55: 234–243. 10.1016/j.biopsych.2003.11.003 Dwivedi Y, Rao JS, Rizavi HS, Kotowski J, Conley RR, Roberts RC, Tamminga CA, Pandey GN: Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60: 273–282. 10.1001/archpsyc.60.3.273 Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Mondal AC, Shukla PK, Conley RR: Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims. Neuropsychopharmacology 2005, 30: 1548–1556. 10.1038/sj.npp.1300765 Dwivedi Y, Mondal AC, Rizavi HS, Faludi G, Palkovits M, Sarosi A, Conley RR, Pandey GN: Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims. Arch Gen Psychiatry 2006, 63: 639–648. 10.1001/archpsyc.63.6.639 Valdizan EM, Gutierrez O, Pazos A: Adenylate cyclase activity in postmortem brain of suicide subjects: reduced response to beta-adrenergic stimulation. Biol Psychiatry 2003, 54: 1457–1464. 10.1016/S0006-3223(03)00589-4 Nishizuka Y: Studies and prospectives of protein kinase C in signal transduction. Nihon Ketsueki Gakkai Zasshi 1988, 51: 1321–1326. Akimoto K, Mizuno K, Osada S, Hirai S, Tanuma S, Suzuki K, Ohno S: A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J Biol Chem 1994, 269: 12677–12683. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y: Protein kinase C zeta subspecies from rat brain: its structure, expression, and properties. Proc Natl Acad Sci U S A 1989, 86: 3099–3103. 10.1073/pnas.86.9.3099 Tanaka C, Nishizuka Y: The protein kinase C family for neuronal signaling. Annu Rev Neurosci 1994, 17: 551–567. 10.1146/annurev.ne.17.030194.003003 Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Conley RR: Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study. Arch Gen Psychiatry 2004, 61: 685–693. 10.1001/archpsyc.61.7.685 Choi K, Le T, Xing G, Johnson LR, Ursano RJ: Analysis of kinase gene expression in the frontal cortex of suicide victims: implications of fear and stress. Front Behav Neurosci 2011, 5: 46. Pandey GN, Dwivedi Y, SridharaRao J, Ren X, Janicak PG, Sharma R: Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients. Neuropsychopharmacology 2002, 26: 216–228. 10.1016/S0893-133X(01)00327-X Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Roberts RC, Conley RR, Tamminga C: Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression. J Psychiatr Res 2003, 37: 421–432. 10.1016/S0022-3956(03)00047-5 Odagaki Y, Garcia-Sevilla JA, Huguelet P, La Harpe R, Koyama T, Guimon J: Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims. Brain Res 2001, 898: 224–231. 10.1016/S0006-8993(01)02188-6 Young LT, Bezchlibnyk YB, Chen B, Wang JF, MacQueen GM: Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment. Biol Psychiatry 2004, 55: 570–577. 10.1016/j.biopsych.2003.10.023 Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Roberts RC, Conley RR: Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. Int J Neuropsychopharmacol 2007, 10: 621–629. Bonaccorso S, Marino V, Biondi M, Grimaldi F, Ippoliti F, Maes M: Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J Affect Disord 2002, 72: 237–241. 10.1016/S0165-0327(02)00264-1 Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, Almerighi C, Levrero M, Egyed B, Bosmans E, Meltzer HY, Maes M: Immunotherapy with interferon- alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res 2001, 105: 45–55. 10.1016/S0165-1781(01)00315-8 Berk M, Wadee AA, Kuschke RH, O'Neill-Kerr A: Acute phase proteins in major depression. J Psychosom Res 1997, 43: 529–534. 10.1016/S0022-3999(97)00139-6 Kubera M, Kenis G, Bosmans E, Zieba A, Dudek D, Nowak G, Maes M: Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol 2000, 52: 237–241. Maes M: Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995, 19: 11–38. 10.1016/0278-5846(94)00101-M Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH: Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology 2010, 35: 2617–2623. 10.1038/npp.2010.159 Minami M, Kuraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M: Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus. Neurosci Lett 1991, 123: 254–256. 10.1016/0304-3940(91)90944-O Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L, Hansson O, Bjorkqvist M, Traskman-Bendz L, Brundin L: Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 2009, 66: 287–292. 10.1016/j.biopsych.2009.01.030 Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C, Bernstein HG, Bogerts B: Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 2008, 42: 151–157. 10.1016/j.jpsychires.2006.10.013 Tonelli LH, Stiller J, Rujescu D, Giegling I, Schneider B, Maurer K, Schnabel A, Moller HJ, Chen HH, Postolache TT: Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand 2008, 117: 198–206. 10.1111/j.1600-0447.2007.01128.x Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA, Roberts RC, Conley RR, Dwivedi Y: Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res 2012, 46: 57–63. 10.1016/j.jpsychires.2011.08.006 Huang EJ, Reichardt LF: Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001, 24: 677–736. 10.1146/annurev.neuro.24.1.677 Nibuya M, Nestler EJ, Duman RS: Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996, 16: 2365–2372. Durany N, Michel T, Kurt J, Cruz-Sanchez FF, Cervas-Navarro J, Riederer P: Brain- derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. Int J Dev Neurosci 2000, 18: 807–813. 10.1016/S0736-5748(00)00046-0 Durany N, Michel T, Zochling R, Boissl KW, Cruz-Sanchez FF, Riederer P, Thome J: Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 2001, 52: 79–86. 10.1016/S0920-9964(00)00084-0 Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN: Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60: 804–815. 10.1001/archpsyc.60.8.804 Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R: Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005, 136: 29–37. 10.1016/j.molbrainres.2004.12.020 Sarchiapone M, Carli V, Roy A, Iacoviello L, Cuomo C, Latella MC, di Giannantonio M, Janiri L, de Gaetano M, Janal MN: Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology 2008, 57: 139–145. 10.1159/000142361 Zai CC, Manchia M, De Luca V, Tiwari AK, Chowdhury NI, Zai GC, Tong RP, Yilmaz Z, Shaikh SA, Strauss J, Kennedy JL: The brain-derived neurotrophic factor gene in suicidal behaviour: a meta-analysis. Int J Neuropsychopharmacol 2012, 15: 1037–1042. 10.1017/S1461145711001313 de Luca V, Souza RP, Zai CC, Panariello F, Javaid N, Strauss J, Kennedy JL, Tallerico T, Wong AH: Parent of origin effect and differential allelic expression of BDNF Val66Met in suicidal behaviour. World J Biol Psychiatry 2011, 12: 42–47. 10.3109/15622975.2010.506928 Ernst C, Deleva V, Deng X, Sequeira A, Pomarenski A, Klempan T, Ernst N, Quirion R, Gratton A, Szyf M, Turecki G: Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch Gen Psychiatry 2009, 66: 22–32. 10.1001/archpsyc.66.1.22 Takebayashi M, Hisaoka K, Nishida A, Tsuchioka M, Miyoshi I, Kozuru T, Hikasa S, Okamoto Y, Shinno H, Morinobu S, Yamawaki S: Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int J Neuropsychopharmacol 2006, 9: 607–612. 10.1017/S1461145705006085 Hisaoka K, Maeda N, Tsuchioka M, Takebayashi M: Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells: a possible contribution to GDNF production. Brain Res 2008, 1196: 53–58. Hisaoka K, Nishida A, Koda T, Miyata M, Zensho H, Morinobu S, Ohta M, Yamawaki S: Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J Neurochem 2001, 79: 25–34. Hisaoka K, Tsuchioka M, Yano R, Maeda N, Kajitani N, Morioka N, Nakata Y, Takebayashi M: Tricyclic antidepressant amitriptyline activates fibroblast growth factor receptor signaling in glial cells: involvement in glial cell line-derived neurotrophic factor production. J Biol Chem 2011, 286: 21118–21128. 10.1074/jbc.M111.224683 Otsuki K, Uchida S, Watanuki T, Wakabayashi Y, Fujimoto M, Matsubara T, Funato H, Watanabe Y: Altered expression of neurotrophic factors in patients with major depression. J Psychiatr Res 2008, 42: 1145–1153. 10.1016/j.jpsychires.2008.01.010 Gilad VH, Rabey JM, Kimiagar Y, Gilad GM: The polyamine stress response: tissue-, endocrine-, and developmental-dependent regulation. Biochem Pharmacol 2001, 61: 207–213. 10.1016/S0006-2952(00)00517-7 Igarashi K, Kashiwagi K: Modulation of cellular function by polyamines. Int J Biochem Cell Biol 2010, 42: 39–51. 10.1016/j.biocel.2009.07.009 Seiler N, Atanassov CL: The natural polyamines and the immune system. Prog Drug Res 1994, 43: 87–141. Fiori LM, Turecki G: Implication of the polyamine system in mental disorders. J Psychiatry Neurosci 2008, 33: 102–110. Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, Casero RA Jr, Rouleau G, Benkelfat C, Turecki G: Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006, 63: 35–48. 10.1001/archpsyc.63.1.35 Fiori LM, Mechawar N, Turecki G: Identification and characterization of spermidine/spermine N1-acetyltransferase promoter variants in suicide completers. Biol Psychiatry 2009, 66: 460–467. 10.1016/j.biopsych.2009.04.002 Klempan TA, Rujescu D, Merette C, Himmelman C, Sequeira A, Canetti L, Fiori LM, Schneider B, Bureau A, Turecki G: Profiling brain expression of the spermidine/spermine N1-acetyltransferase 1 (SAT1) gene in suicide. Am J Med Genet B Neuropsychiatr Genet 2009, 150B: 934–943. 10.1002/ajmg.b.30920 Guipponi M, Deutsch S, Kohler K, Perroud N, Le Gal F, Vessaz M, Laforge T, Petit B, Jollant F, Guillaume S, Baud P, Courtet P, La Harpe R, Malafosse A: Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 2009, 150B: 799–807. 10.1002/ajmg.b.30901 Fiori LM, Turecki G: Epigenetic regulation of spermidine/spermine N1- acetyltransferase (SAT1) in suicide. J Psychiatr Res 2011, 45: 1229–1235. 10.1016/j.jpsychires.2011.03.015 Fiori LM, Bureau A, Labbe A, Croteau J, Noel S, Merette C, Turecki G: Global gene expression profiling of the polyamine system in suicide completers. Int J Neuropsychopharmacol 2011, 14: 595–605. 10.1017/S1461145710001574 Fiori LM, Wanner B, Jomphe V, Croteau J, Vitaro F, Tremblay RE, Bureau A, Turecki G: Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide. PLoS One 2010, 5: e15146. 10.1371/journal.pone.0015146 Chen GG, Fiori LM, Moquin L, Gratton A, Mamer O, Mechawar N, Turecki G: Evidence of altered polyamine concentrations in cerebral cortex of suicide completers. Neuropsychopharmacology 2010, 35: 1477–1484. 10.1038/npp.2010.17 Chen GG, Turecki G, Mamer OA: A quantitative GC-MS method for three major polyamines in postmortem brain cortex. J Mass Spectrom 2009, 44: 1203–1210. 10.1002/jms.1597 Carroll BJ: The dexamethasone suppression test for melancholia. Br J Psychiatry 1982, 140: 292–304. 10.1192/bjp.140.3.292 Holsboer F: The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23: 477–501. 10.1016/S0893-133X(00)00159-7 Nemeroff CB: The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1996, 1: 336–342. Yerevanian BI, Feusner JD, Koek RJ, Mintz J: The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J Affect Disord 2004, 83: 103–108. 10.1016/j.jad.2004.08.009 Coryell W, Schlesser M: The dexamethasone suppression test and suicide prediction. Am J Psychiatry 2001, 158: 748–753. 10.1176/appi.ajp.158.5.748 Banki CM, Arato M, Papp Z, Kurcz M: Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J Affect Disord 1984, 6: 341–350. 10.1016/S0165-0327(84)80012-9 Targum SD, Rosen L, Capodanno AE: The dexamethasone suppression test in suicidal patients with unipolar depression. Am J Psychiatry 1983, 140: 877–879. Black DW, Monahan PO, Winokur G: The relationship between DST results and suicidal behavior. Ann Clin Psychiatry 2002, 14: 83–88. 10.3109/10401230209149094 Brown RP, Mason B, Stoll P, Brizer D, Kocsis J, Stokes PE, Mann JJ: Adrenocortical function and suicidal behavior in depressive disorders. Psychiatry Res 1986, 17: 317–323. 10.1016/0165-1781(86)90079-X Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF: Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994, 60: 436–444. 10.1159/000126778 Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H: Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 2004, 24: 1478–1485. 10.1523/JNEUROSCI.4734-03.2004 Merali Z, Kent P, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Bedard T, Anisman H: Corticotropin-releasing hormone, arginine vasopressin, gastrin- releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol Psychiatry 2006, 59: 594–602. 10.1016/j.biopsych.2005.08.008 Austin MC, Janosky JE, Murphy HA: Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry 2003, 8: 324–332. 10.1038/sj.mp.4001250 Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M: Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 1988, 45: 577–579. 10.1001/archpsyc.1988.01800300075009 Hiroi N, Wong ML, Licinio J, Park C, Young M, Gold PW, Chrousos GP, Bornstein SR: Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol Psychiatry 2001, 6: 540–546. 10.1038/sj.mp.4000908 Pariante CM: Glucocorticoid receptor function in vitro in patients with major depression. Stress 2004, 7: 209–219. 10.1080/10253890500069650 Perlman WR, Webster MJ, Kleinman JE, Weickert CS: Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol Psychiatry 2004, 56: 844–852. 10.1016/j.biopsych.2004.09.006 Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS: Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 2002, 7: 985–994. 10.1038/sj.mp.4001139 Lopez JF, Palkovits M, Arato M, Mansour A, Akil H, Watson SJ: Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology 1992, 56: 491–501. 10.1159/000126266 McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonte B, Szyf M, Turecki G, Meaney MJ: Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009, 12: 342–348. 10.1038/nn.2270 Supriyanto I, Sasada T, Fukutake M, Asano M, Ueno Y, Nagasaki Y, Shirakawa O, Hishimoto A: Association of FKBP5 gene haplotypes with completed suicide in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35: 252–256. 10.1016/j.pnpbp.2010.11.019 Fountoulakis M, Hardmeier R, Hoger H, Lubec G: Postmortem changes in the level of brain proteins. Exp Neurol 2001, 167: 86–94. 10.1006/exnr.2000.7529 Kim CD, Seguin M, Therrien N, Riopel G, Chawky N, Lesage AD, Turecki G: Familial aggregation of suicidal behavior: a family study of male suicide completers from the general population. Am J Psychiatry 2005, 162: 1017–1019. 10.1176/appi.ajp.162.5.1017